Department of Surgery, C206 Division of General Surgery, University of Kentucky College of Medicine, 800 Rose Street, Lexington, Kentucky 40536-0298, USA.
J Surg Res. 2013 Jan;179(1):e183-7. doi: 10.1016/j.jss.2012.01.054. Epub 2012 Apr 1.
Transfusion of packed red blood cells (PRBCs) is associated with morbidity and mortality. The mechanisms are not fully understood. Packed red blood cells deplete extracellular arginine and possess transporters for arginine, an amino acid essential for normal immunity. We hypothesize that the membrane y+ amino acid transporter contributes to arginine depletion in PRBCs.
We titrated PRBCs to a 10% hematocrit with phosphate-buffered saline, blocked PRBC y+ transporters using n-ethylmaleimide (0.2 mM), and measured arginine and ornithine levels using liquid chromatography-mass spectroscopy. We added radiolabeled L-arginine [4,5-(3)H] (10 μmol/L) added to similar culture conditions and measured arginine uptake in counts per minute (CPM). We examined storage periods of 6-9 d, 1-4 wk, and 6 wk, and correlated donor demographics with arginine uptake.
n-Ethylmaleimide blockade of y+ transporters impaired PRBC arginine depletion from culture media (117.6 ± 8.6 μM versus 76.9 ± 5.8 μM; P < 0.001) and reduced intracellular L-arginine (7,574 ± 955 CPM versus 18,192 ± 1,376 CPM; P < 0.01). Arginine depletion increased with storage duration (1 wk versus 6 wk; P < 0.002). With n-ethylmaleimide treatment, 6-wk-old PRBCs preserved more culture arginine (P < 0.008) than at shorter durations. Nine-day storage duration increased L-arginine uptake compared with 6- to 8-day storage (n = 77, R = 0.225, P < 0.05). Extracellular arginine depletion and extracellular ornithine synthesis varied among donors and correlated inversely (R = -0.5, P = 0.01).
Membrane y+ transporters are responsible for arginine depletion by PRBCs. Membrane y+ activity increases with storage duration. Arginine uptake varies among donors. Membrane biology of RBCs may have a role in the negative clinical effects associated with PRBC transfusion.
输注浓缩红细胞(PRBC)与发病率和死亡率有关。其机制尚不完全清楚。PRBC 会耗尽细胞外精氨酸,并具有精氨酸转运体,而精氨酸是正常免疫所必需的氨基酸。我们假设细胞膜 y+氨基酸转运体有助于 PRBC 中的精氨酸耗尽。
我们用磷酸盐缓冲盐水将 PRBC 滴定至 10%的血细胞比容,用 N-乙基马来酰亚胺(0.2 mM)阻断 PRBC y+转运体,并使用液相色谱-质谱法测量精氨酸和鸟氨酸水平。我们在类似的培养条件下加入放射性标记的 L-精氨酸[4,5-(3)H](10 μmol/L),并以每分钟计数(CPM)测量精氨酸摄取量。我们检查了 6-9 天、1-4 周和 6 周的储存期,并将供体人口统计学与精氨酸摄取相关联。
y+转运体的 N-乙基马来酰亚胺阻断会损害 PRBC 从培养基中耗尽精氨酸(117.6 ± 8.6 μM 与 76.9 ± 5.8 μM;P < 0.001),并减少细胞内 L-精氨酸(7,574 ± 955 CPM 与 18,192 ± 1,376 CPM;P < 0.01)。精氨酸的消耗随着储存时间的延长而增加(1 周与 6 周;P < 0.002)。用 N-乙基马来酰亚胺处理后,6 周龄的 PRBC 比在较短时间内保存更多的培养精氨酸(P < 0.008)。与 6-8 天的储存相比,9 天的储存时间增加了 L-精氨酸的摄取(n = 77,R = 0.225,P < 0.05)。供体之间的细胞外精氨酸耗竭和细胞外鸟氨酸合成各不相同,呈负相关(R = -0.5,P = 0.01)。
细胞膜 y+转运体是 PRBC 耗尽精氨酸的原因。膜 y+活性随储存时间的延长而增加。精氨酸摄取量在供体之间有所不同。RBC 膜生物学可能在与 PRBC 输血相关的负面临床影响中起作用。